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To study mechanisms driving/inhibiting skin carcinogenesis, transgenic mice have been 
established that express activated H-ras or fos oncogenes and RU486-inducible ablation 
of PTEN-mediated AKT inactivation [Δ5PTEN]. Tri-genic HK1.ras-fos-Δ5Pten mice exhibit 
papillomas that convert to well-differentiated SCC following p53 loss associated with a 
suprabasal-to-basal increases in Mdm2 activation (p-Mdm2166). Given that 1433σ/Stratifin 
stabilises p53 levels by binding to Mdm2 and its resultant removal by auto-ubiquitination, 
this study investigated whether Stratifin over-expression could inhibit malignant conversion 
via maintanance of elevated p53 levels; a mechanism observed in bi-genic HK1.fos-
Δ5PTEN and HK1.ras-Δ5PTEN mice. Initially mice expressing Stratifin in epidermis and hair 
follicles from a Keratin 14 promoter [K14strat] were crossed with HK1fos mice [HK1fos-
strat]. However, instead of the predicted inhibition of benign phenotypes, HK1fos-strat mice 
exhibited a rapid tumourigenesis which quickly converted to malignancy; whereas HK1fos 
controls exhibited pre-neoplastic hyperplasia [over ~9mo] and K14strat exhibited only mild 
epidermal hypoplasia. Histological analysis revealed that early [2-3 weeks] HK1.fos-strat 
epidermis exhibited hyperplasia/hyperkeratosis which rapidly progressed to overt tumours 
that exhibited a novel histotype. HK1fos-strat epidermis displayed loss of correct 
stratification, accompanied by a pronounced disorder to supra-basal differentiation; with 
expansion of a distinct, multi-layered basal layer being another unique feature. By 4-5 weeks, 
overt tumours had appeared that lacked or exhibited a highly disrupted granular layer, with 
faint keratohyalin granules spread throughout highly disordered upper differentiating layers, 
as determined by immunefluorescence analysis of keratins K1/K10/K14 and loricrin and 
filaggrin. However, in older HK1.fos-strat tumours [~7 weeks] the paramount feature was a 
significant tricholemmal keratinisation. These HK1.fos-strat tumours also exhibited loss of 
Keratin 1 expression, indicative of malignant conversion, with extensive pleomorphism and 
neoangiogenesis with erythrocyte extravasation. While many of these traits were shared with 
HK1.ras-fos-Δ5PTEN and human cutaneous SCCs, the tricholemmal keratinisation differs 
quite markedly and appears similar to human cutaneous SCC of follicular origin (fSCC, 
tricholemmal carcinoma). These adnexal neoplasms arise in HF walls and are a relatively 
underdiagnosed tumour type. In addition to histological similarities Keratin 17, normally 
expressed in follicular ORS, was expressed in HK1.fos-strat  fSCCs; appearing as small rings 
of cells, as observed in human fSCCs; whereas normal and HK1.fos skin exhibit K17 
confined to follicular ORS and was absent in HK1.ras-fos papillomas, HK1.fos-
Δ5PTEN keratoacanthomas or HK1.ras-fos-Δ5PTEN SCCs. Collectively, these data suggest 
HK1.fos-strat tumours are a putative paradigm for human SCC of follicular origin. 
